Heart device monitoring to help guide heart failure treatment
Part of Heart & circulation clinical trials.
This trial uses a special feature in your implanted heart device (ICD or CRT-D) called HeartLogic. It helps your doctor know if your heart failure is getting worse so they can adjust your medications early and keep you out of the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your heart's ejection fraction (the amount of blood your heart pumps out per beat) is 35% or less.
- You have had a hospital stay for heart failure in the last 2 years, or you had symptoms like severe shortness of breath (NYHA class III or IV) in the last year that was treated without a hospital stay.
- You have a heart device (ICD or CRT-D) that can use HeartLogic, or you are getting one soon.
- You are not on dialysis for kidney failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using HeartLogic, a feature in your heart device that tracks early warning signs, can help your care team manage your heart failure better and keep you out of the hospital. If you already have a compatible CRT-D or ICD and use remote monitoring, you may be able to join.
This study tests whether a special monitoring system in your heart device (called HeartLogic) can help detect early warning signs of heart failure getting worse. It uses wireless check-ins to track your condition at home and alert your doctor if you need help.
This trial tests if a smartphone app or similar remote tools can help doctors catch early signs that heart failure is getting worse in people who have a defibrillator (ICD) or biventricular pacemaker (CRT) that sends data to the clinic. Participating helps researchers figure out if this type of check-in from home works better than standard care.
This study tests a heart failure alert system called HeartInsight in people who recently received an ICD or CRT-D device. The goal is to see if the alerts help doctors manage care better. You may qualify if you got a new (not replacement) device less than a year ago.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial tests a home monitoring system called Cardiosignal to help manage heart failure after an emergency room visit. It may help doctors adjust your treatments to keep you healthier at home.
Hear when a new Congestive Heart Failure Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.